Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 10 studies | 35% ± 16% | |
Mueller cell | 6 studies | 39% ± 20% | |
glutamatergic neuron | 5 studies | 43% ± 18% | |
astrocyte | 4 studies | 28% ± 7% | |
GABAergic neuron | 3 studies | 32% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 30% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1227.42 | 2637 / 2642 | 99% | 17.08 | 700 / 705 |
kidney | 94% | 789.63 | 84 / 89 | 65% | 2.68 | 588 / 901 |
prostate | 85% | 394.04 | 209 / 245 | 20% | 0.32 | 100 / 502 |
intestine | 78% | 661.50 | 756 / 966 | 25% | 0.54 | 134 / 527 |
esophagus | 60% | 377.98 | 869 / 1445 | 28% | 0.78 | 51 / 183 |
heart | 88% | 520.77 | 754 / 861 | 0% | 0 | 0 / 0 |
lung | 61% | 170.16 | 351 / 578 | 12% | 0.43 | 135 / 1155 |
bladder | 52% | 169.29 | 11 / 21 | 14% | 0.40 | 73 / 504 |
liver | 25% | 64.02 | 56 / 226 | 41% | 1.53 | 168 / 406 |
lymph node | 0% | 0 | 0 / 0 | 55% | 2.20 | 16 / 29 |
eye | 0% | 0 | 0 / 0 | 50% | 1.66 | 40 / 80 |
pancreas | 1% | 1.90 | 3 / 328 | 48% | 0.96 | 85 / 178 |
ovary | 6% | 19.11 | 11 / 180 | 35% | 0.98 | 151 / 430 |
stomach | 13% | 28.51 | 45 / 359 | 26% | 0.63 | 74 / 286 |
uterus | 12% | 27.70 | 21 / 170 | 14% | 0.53 | 65 / 459 |
adipose | 26% | 93.32 | 308 / 1204 | 0% | 0 | 0 / 0 |
skin | 0% | 0.75 | 6 / 1809 | 20% | 1.00 | 93 / 472 |
peripheral blood | 14% | 86.93 | 134 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 2% | 22.83 | 6 / 258 | 11% | 0.60 | 26 / 230 |
breast | 1% | 1.23 | 4 / 459 | 11% | 0.21 | 120 / 1118 |
thymus | 2% | 3.94 | 14 / 653 | 9% | 0.17 | 53 / 605 |
blood vessel | 8% | 18.02 | 113 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.07 | 2 / 45 |
muscle | 3% | 6.20 | 24 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030073 | Biological process | insulin secretion |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0050868 | Biological process | negative regulation of T cell activation |
GO_0030154 | Biological process | cell differentiation |
GO_0031016 | Biological process | pancreas development |
GO_0009749 | Biological process | response to glucose |
GO_0048873 | Biological process | homeostasis of number of cells within a tissue |
GO_0070160 | Cellular component | tight junction |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0005634 | Cellular component | nucleus |
Gene name | ILDR2 |
Protein name | Immunoglobulin like domain containing receptor 2 Immunoglobulin-like domain-containing receptor 2 (Angulin-3) |
Synonyms | C1orf32 |
Description | FUNCTION: May be involved in ER stress pathways with effects on lipid homeostasis and insulin secretion. With ILDR1 and LSR, involved in the maintain of the epithelial barrier function through the recruitment of MARVELD2/tricellulin to tricellular tight junctions (By similarity). Also functions as a B7-like protein family member expressed on immune cells and inflamed tissue and with T-cell inhibitory activity . In the inner ear, may regulate alternative pre-mRNA splicing via binding to TRA2A, TRA2B and SRSF1 (By similarity). . |
Accessions | ENST00000271417.8 Q71H61 E9PQC8 E9PPL0 E9PNU3 E9PLS0 E9PR23 ENST00000529071.5 ENST00000469934.6 ENST00000529387.5 ENST00000528703.5 ENST00000526687.1 ENST00000525740.5 E9PRA4 |